Archive
FTSE 100 closes lower as US sinks with Santa rally looking a vague memory
At the close, the FTSE 100 was down 71.93 points, or 1.1% at 6,773.24, just above the session low of 6,761.37 and well below the early high of 6,845.17.
Company
Physiomics PLC
LON:PYC
Physiomics PLC combines expertise across modelling & simulation, biostatistics, data science and bioinformatics, together with deep biology expertise, to help biotech and pharma companies streamline their drug development journeys. The company's approach is to help derive insight from all relevant and often disparate data in order to de-risk decision making and optimise research design across discovery, pre-clinical and clinical studies.
76 stories · page 3 of 4
Archive
Proactive news snapshot: Ceres Power, Immotion Group, MySQUAR, Physiomics...
A glance at some of the day's highlights from the Proactive Investors newswire
Physiomics’ annual revenue doubles thanks to lucrative Merck KGaA contract win
On top of the Merck KGaA win, Physiomics inked deals with several other pharma and biotech groups last year
Investments and investor services
FTSE 100 closes firmly in red as Italy causes jitters
In the currency markets, sterling is around flat against the Euro and down 0.43% against the US dollar.
Physiomics zips higher with trading ahead of expectations
The AIM-quoted firm expects revenues to almost double from last year, while losses should be “materially” lower than current market forecasts
OnTheMarket shares climb above property portal group’s 165p float price for the first time
Some of the main news-driven risers and fallers in London on Wednesday afternoon ...
Zoltav shares jump as it discovers reservoir on Bortovoy licence may be larger than expected
A look at some of the biggest risers and fallers in London on Wednesday
Archive
Breakfast News -
Ohhhh yes! Direct Line's trading update provides insurer with a lift
A look at some of the biggest risers and fallers in London on Friday
Paternoster Resources hooks investors as it unveils bid to reduce costs
Proactive takes a look at the movers and shakers in London
Physiomics lands pre-clinical contract for virtual tumour tech
Physiomics' Virtual Tumour is a sophisticated computer model that simulates tumour cell division
Archive
SMALL CAP MOVERS: Physiomics pocket rocket stock of the week after completing virtual tumour project
A look back at some of the more interesting stories on the junior market this week
Investments and investor services
Parallel Media and Physiomics lead small cap market gainers
Some of the biggest risers and fallers in London on Wednesday
Physiomics and Merck team up to progress Virtual Tumour technology
This is a significant milestone for the company as it will generate long-term revenues with management expecting income of £500,000 to be realised in the first 12 months.
Contract news lift for Physiomics, Rosslyn Data Technologies
A glance at some of the bigger risers and fallers today in London ...